Amarin reported $126.83M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
AbbVie USD 12.48B 110M Mar/2026
Alnylam Pharmaceuticals USD 912.74M 28.78M Jun/2026
Amarin USD 126.83M 477K Dec/2025
AstraZeneca USD 18.86B 972M Jun/2026
BioCryst Pharmaceuticals USD 110.76M 3.94M Jun/2026
DBV Technologies USD 15.1M 1.05M Mar/2026
GlaxoSmithKline GBP 8.07B 137M Jun/2026
Halozyme Therapeutics USD 453.33M 4.66M Jun/2026
Heron Therapeutics USD 89.59M 8.54M Dec/2025
Ionis Pharmaceuticals USD 58.84M 15.16M Jun/2026
Nektar Therapeutics USD 3.6M 1.82M Mar/2026
Neurocrine Biosciences USD 887M 118.9M Jun/2026
Novartis USD 9.85B 252M Jun/2026